Simon, Christopher 4
4 · HAEMONETICS CORP · Filed May 21, 2024
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-05-17+14,624→ 265,035 total - Tax Payment
Common Stock
2024-05-17$95.73/sh−4,037$386,462→ 250,411 total - Award
Non-qualified Stock Option (Right to Buy)
2024-05-17+32,140→ 32,140 totalExercise: $95.73Exp: 2031-05-17→ Common Stock (32,140 underlying)
Footnotes (5)
- [F1]Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
- [F2]This number includes unvested RSUs previously reported.
- [F3]The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F4]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F5]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.